[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Proton Pump Inhibitor Drug Market Report 2017

April 2017 | 104 pages | ID: U6CF29B5A46EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Proton Pump Inhibitor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Proton Pump Inhibitor Drug in these regions, from 2012 to 2022 (forecast).
United States Proton Pump Inhibitor Drug market competition by top manufacturers/players, with Proton Pump Inhibitor Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca
  • Cadila Pharmaceuticals
  • Eisai
  • Eli Lilly
  • Janssen
  • Pfizer
  • Santarus
  • Wyeth
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Omeprazole
  • Lansoprazole
  • Pantoprazole
  • Rabeprazole
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Proton Pump Inhibitor Drug for each application, including
  • Hospital
  • Laboratory
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Proton Pump Inhibitor Drug Market Report 2017

1 PROTON PUMP INHIBITOR DRUG OVERVIEW

1.1 Product Overview and Scope of Proton Pump Inhibitor Drug
1.2 Classification of Proton Pump Inhibitor Drug by Product Category
  1.2.1 United States Proton Pump Inhibitor Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Proton Pump Inhibitor Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Omeprazole
  1.2.4 Lansoprazole
  1.2.5 Pantoprazole
  1.2.6 Rabeprazole
  1.2.7 Others
1.3 United States Proton Pump Inhibitor Drug Market by Application/End Users
  1.3.1 United States Proton Pump Inhibitor Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Laboratory
  1.3.4 Others
1.4 United States Proton Pump Inhibitor Drug Market by Region
  1.4.1 United States Proton Pump Inhibitor Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
  1.4.5 New England Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
  1.4.6 The South Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Proton Pump Inhibitor Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Proton Pump Inhibitor Drug (2012-2022)
  1.5.1 United States Proton Pump Inhibitor Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Proton Pump Inhibitor Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROTON PUMP INHIBITOR DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Proton Pump Inhibitor Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Proton Pump Inhibitor Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Proton Pump Inhibitor Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Proton Pump Inhibitor Drug Market Competitive Situation and Trends
  2.4.1 United States Proton Pump Inhibitor Drug Market Concentration Rate
  2.4.2 United States Proton Pump Inhibitor Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Proton Pump Inhibitor Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROTON PUMP INHIBITOR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Proton Pump Inhibitor Drug Sales and Market Share by Region (2012-2017)
3.2 United States Proton Pump Inhibitor Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Proton Pump Inhibitor Drug Price by Region (2012-2017)

4 UNITED STATES PROTON PUMP INHIBITOR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Proton Pump Inhibitor Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Proton Pump Inhibitor Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Proton Pump Inhibitor Drug Price by Type (2012-2017)
4.4 United States Proton Pump Inhibitor Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROTON PUMP INHIBITOR DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Proton Pump Inhibitor Drug Sales and Market Share by Application (2012-2017)
5.2 United States Proton Pump Inhibitor Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROTON PUMP INHIBITOR DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cadila Pharmaceuticals
  6.2.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cadila Pharmaceuticals Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eisai
  6.3.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eisai Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Janssen
  6.5.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Janssen Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Santarus
  6.7.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Santarus Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Wyeth
  6.8.2 Proton Pump Inhibitor Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Wyeth Proton Pump Inhibitor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 PROTON PUMP INHIBITOR DRUG MANUFACTURING COST ANALYSIS

7.1 Proton Pump Inhibitor Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Proton Pump Inhibitor Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Proton Pump Inhibitor Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Proton Pump Inhibitor Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROTON PUMP INHIBITOR DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Proton Pump Inhibitor Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Proton Pump Inhibitor Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Proton Pump Inhibitor Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Proton Pump Inhibitor Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Proton Pump Inhibitor Drug
Figure United States Proton Pump Inhibitor Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Omeprazole Product Picture
Figure Lansoprazole Product Picture
Figure Pantoprazole Product Picture
Figure Rabeprazole Product Picture
Figure Others Product Picture
Figure United States Proton Pump Inhibitor Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Proton Pump Inhibitor Drug by Application in 2016
Figure Hospital Examples
Figure Laboratory Examples
Figure Others Examples
Figure United States Proton Pump Inhibitor Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Proton Pump Inhibitor Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Proton Pump Inhibitor Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Proton Pump Inhibitor Drug Sales Share by Players/Suppliers
Figure 2017 United States Proton Pump Inhibitor Drug Sales Share by Players/Suppliers
Figure United States Proton Pump Inhibitor Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Proton Pump Inhibitor Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Proton Pump Inhibitor Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Proton Pump Inhibitor Drug Revenue Share by Players/Suppliers
Figure 2017 United States Proton Pump Inhibitor Drug Revenue Share by Players/Suppliers
Table United States Market Proton Pump Inhibitor Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Proton Pump Inhibitor Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Proton Pump Inhibitor Drug Market Share of Top 3 Players/Suppliers
Figure United States Proton Pump Inhibitor Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Proton Pump Inhibitor Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Proton Pump Inhibitor Drug Product Category
Table United States Proton Pump Inhibitor Drug Sales (K Pcs) by Region (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales Share by Region (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Share by Region (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Market Share by Region in 2016
Table United States Proton Pump Inhibitor Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Proton Pump Inhibitor Drug Revenue Share by Region (2012-2017)
Figure United States Proton Pump Inhibitor Drug Revenue Market Share by Region (2012-2017)
Figure United States Proton Pump Inhibitor Drug Revenue Market Share by Region in 2016
Table United States Proton Pump Inhibitor Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales (K Pcs) by Type (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales Share by Type (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Share by Type (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Market Share by Type in 2016
Table United States Proton Pump Inhibitor Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Proton Pump Inhibitor Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Proton Pump Inhibitor Drug by Type (2012-2017)
Figure Revenue Market Share of Proton Pump Inhibitor Drug by Type in 2016
Table United States Proton Pump Inhibitor Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Growth Rate by Type (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales (K Pcs) by Application (2012-2017)
Table United States Proton Pump Inhibitor Drug Sales Market Share by Application (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Market Share by Application (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Market Share by Application in 2016
Table United States Proton Pump Inhibitor Drug Sales Growth Rate by Application (2012-2017)
Figure United States Proton Pump Inhibitor Drug Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Cadila Pharmaceuticals Basic Information List
Table Cadila Pharmaceuticals Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cadila Pharmaceuticals Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Cadila Pharmaceuticals Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Cadila Pharmaceuticals Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Eisai Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Eisai Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Janssen Basic Information List
Table Janssen Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Janssen Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Janssen Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Pfizer Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Santarus Basic Information List
Table Santarus Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Santarus Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Santarus Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Santarus Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Wyeth Basic Information List
Table Wyeth Proton Pump Inhibitor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wyeth Proton Pump Inhibitor Drug Sales Growth Rate (2012-2017)
Figure Wyeth Proton Pump Inhibitor Drug Sales Market Share in United States (2012-2017)
Figure Wyeth Proton Pump Inhibitor Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Proton Pump Inhibitor Drug
Figure Manufacturing Process Analysis of Proton Pump Inhibitor Drug
Figure Proton Pump Inhibitor Drug Industrial Chain Analysis
Table Raw Materials Sources of Proton Pump Inhibitor Drug Major Players/Suppliers in 2016
Table Major Buyers of Proton Pump Inhibitor Drug
Table Distributors/Traders List
Figure United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Proton Pump Inhibitor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Proton Pump Inhibitor Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Proton Pump Inhibitor Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Proton Pump Inhibitor Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Proton Pump Inhibitor Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories